Analysis of the expression of candidate genes for type 1 diabetes susceptibility in T cells

Endocrine Journal

Volumn 61, Issue 6, 2014, Pages 577-588

  Hisanaga Oishi, Yuko ^a   Nishiwaki Ueda, Yumiko ^a   Nojima, Koji ^a   Ueda, Hironori ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Genetic susceptibility genes; Nonobese diabetic (NOD) mice; Transforming growth factor ; Type 1 diabetes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CD4+ T LYMPHOCYTE; CLEC16A GENE; CONTROLLED STUDY; CTLA4 GENE; DLK1 GENE; EL4 CELL LINE; FEMALE; FOXP3 GENE; GENE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IL2 GENE; INSULIN DEPENDENT DIABETES MELLITUS; JURKAT CELL LINE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PTPN22 GENE; RNLS GENE; SH2B3 GENE; SIGNAL TRANSDUCTION; ZAC1 GENE; ANIMAL; C57BL MOUSE; EXPERIMENTAL DIABETES MELLITUS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JURKAT CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; T-LYMPHOCYTES;

EID: 84903596084     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0002     Document Type: Article

References (57)

1. Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85: 291-297.
2. Castano L, Eisenbarth GS (1990) Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8: 647-679.
3. Roep BO, Peakman M (2011) Diabetogenic T lymphocytes in human type 1 diabetes. Curr Opin Immunol 23: 746-753.
4. Kikutani H, Makino S (1992) The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51: 285-322.
5. Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485.
6. Wicker LS, Clark J, Fraser HI, Garner VE, Gonzalez-Munoz A, et al. (2005) Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 25 Suppl: 29-33.
7. Cucca F, Lampis R, Congia M, Angius E, Nutland S, et al. (2001) A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10: 2025-2037.
8. Stadinski B, Kappler J, Eisenbarth GS (2010) Molecular targeting of islet autoantigens. Immunity 32: 446-456.
9. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731-2738.
10. Hakonarson H, Grant SF, Bradfeld JP, Marchand L, Kim CE, et al. (2007) A genome-wide association study identifes KIAA0350 as a type 1 diabetes gene. Nature 448: 591-594.
11. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, et al. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39: 857-864.
12. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, et al. (2009) Genome-wide association study and meta-analysis fnd that over 40 loci affect risk of type 1 diabetes. Nat Genet 41: 703-707.
13. Pociot F, Akolkar B, Concannon P, Erlich HA, Julier C, et al. (2010) Genetics of type 1 diabetes: what's next? Diabetes 59: 1561-1571.
14. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
15. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
16. Zhang Y, Bandala-Sanchez E, Harrison LC (2012) Revisiting regulatory T cells in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 19: 271-278.
17. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, et al. (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153.
18. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
19. Davidson TS, DiPaolo RJ, Andersson J, Shevach EM (2007) Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 178: 4022-4026.
20. Zhang N, Bevan MJ (2012) TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol 13: 667-673.
21. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, et al. (2007) Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcrip-tional signature. Immunity 27: 786-800.
22. Fu W, Ergun A, Lu T, Hill JA, Haxhinasto S, et al. (2012) A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nat Immunol 13: 972-980.
23. Ueda H, Ikegami H, Kawaguchi, Fujisawa T, Nojima K, et al. (2000) Paternal-maternal effects on pheno-typic characteristics in spontaneously diabetic Nagoya-Shibata-Yasuda mice. Metabolism 49: 651-656.
24. Patel H, Chen J, Das KC, Kavdia M (2013) Hyperglycemia induces differential change in oxida-tive stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovasc Diabetol 12: 142-155.
25. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, et al. (1980) Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu (Exp Anim) 29: 1-13.
26. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, et al. (1986) The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231: 733-735.
27. Woodrow M, Clipstone NA, Cantrell D (1993) P21ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J Exp Med 178: 1517-1522.
28. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, et al. (2008) Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9: 194-202.
29. Weiss A, Wiskocil RL, Stobo JD (1984) The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production refects events occurring at a pre-translational level. J Immunol 133: 123-128.
30. Combs J, Kim SJ, Tan S, Ligon LA, Holzbaur EL, et al. (2006) Recruitment of dynein to the Jurkat immuno-logical synapse. Proc Natl Acad Sci U S A 103: 14883-14888.
31. Huang SM, Stallcup MR (2000) Mouse Zac1, a tran-scriptional coactivator and repressor for nuclear receptors. Mol Cell Biol 20: 1855-1867.
32. Ueda H, Morphew MK, McIntosh JR, Davis MM (2011) CD4+ T-cell synapses involve multiple distinct stages. Proc Natl Acad Sci U S A 108: 17099-17104.
33. Spengler D, Villalba M, Hoffmann A, Pantaloni C, Houssami S, et al. (1997) Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc fnger protein expressed in the pituitary gland and the brain. EMBO J 16: 2814-2825.
34. Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, et al. (2000) The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes. Hum Mol Genet 9: 453-460.
35. Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, et al. (2006) Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell 11: 711-722.
36. Barz T, Hoffmann A, Panhuysen M, Spengler D (2006) Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation. Cancer Res 66: 11975-11982.
37. Peng Y, Laouar Y, Li MO, Green EA, Flavell RA (2004) TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A 101: 4572-4577.
38. Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, et al. (2007) Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39: 329-337.
39. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
40. Winkler C, Krumsiek J, Lempainen J, Achenbach P, Grallert H, et al. (2012) A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun 13: 549-555.
41. Howson JM, Cooper JD, Smyth DJ, Walker NM, Stevens H, et al. (2012) Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes. Diabetes 61: 3012-3017.
42. Herold KC, Vignali DA, Cooke A, Bluestone JA (2013) Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 13: 243-256.
43. Xie J, Tato CM, Davis MM (2013) How the immune system talks to itself: the varied role of synapses. Immunol Rev 251: 65-79.
44. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, et al. (2008) Meta-analysis of genome-wide association study data identifes additional type 1 diabetes risk loci. Nat Genet 40: 1399-1401.
45. Yokoi N, Komeda K, Wang HY, Yano H, Kitada K, et al. (2002) Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 31: 391-394.
46. Rainbow DB, Moule C, Fraser HI, Clark J, Howlett SK, et al. (2011) Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice. J Immunol 187: 325-336.
47. Yamashita H, Awata T, Kawasaki E, Ikegami H, Tanaka S, et al. (2011) Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes. Diabetes Metab Res Rev 27: 844-848.
48. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
49. Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA, et al. (2009) The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 42: 68-71.
50. Hakonarson H, Qu HQ, Bradfeld JP, Marchand L, Kim CE, et al. (2008) A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes 57: 1143-1146.
51. Swafford AD, Howson JM, Davison LJ, Wallace C, Smyth DJ, et al. (2011) An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes. Diabetes 60: 1041-1044.
52. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, et al. (2005) Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76: 773-779.
53. Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, et al. (2007) Large-scale genetic fne mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 39: 1074-1082.
54. Raj SM, Howson JM, Walker NM, Cooper JD, Smyth DJ, et al. (2009) No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 52: 2109-2116.
55. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36: 337-338.
56. Concannon P, Onengut-Gumuscu S, Todd JA, Smyth DJ, Pociot F, et al. (2008) A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 57: 2858-2861.
57. Fraser HI, Dendrou CA, Healy B, Rainbow DB, Howlett S, et al. (2010) Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene. J Immunol 184: 5075-5084.